ABSTRACT
Article Received on
20 March 2015, A Reverse Phase High Performance Liquid Chromatographic method
Revised on 11 April 2015, was developed for the simultaneous estimation of Bromhexine
Accepted on 02 May 2015
Hydrochloride, Guaiphenesin and Chlorpheniramine Maleate. The
separation was achieved by C18 column (2504.6 mm, 5 m Particle
*Correspondence for Size) with the mobile phase consisting of 0.01 M Potassium
Author dihydrogen Phosphate Buffer pH-3 adjusted with 1% of Ortho
Dr. Ankit B. Chaudhary
Phosphoric Acid: Acetonitrile (40:60% v/v). Detection was carried out
Saraswati Institute of
at 254 nm. RP-HPLC method gives retention time of Bromhexine
Pharmaceutical Sciences,
Dhanap, Gandhinagar, Hydrochloride (BH), Guaiphenesin (GP) and Chlorpheniramine
382355, India. Maleate (CPM) was found to be 5.54min, 2.03min and 6.61 min
respectively. The method has been validated for ICH Guideline.
Linearity for Bromhexine Hydrochloride, Guaiphenesin and Chlorpheniramine Maleate were
found in the range of 10-60 g/ml, 125-750g/ml and 5-30 g/ml. The percentage recoveries
obtained for BH, GP and CPM were found to be in range of 99.40-101.95%, 100.63-101.51%
and100.64-101.51% respectively in tablet. Limit of detection and Limit of quantification was
found to be 1.449g/ml and 4.830g/ml for BH, 15.02g/ml and 50.08g/ml for GP and
0.795g/ml and 2.651g/ml for CPM respectively.
INTRODUCTION
Bromhexine Hydrochloride (BH) is a 3, 5Dibromo-N (alpha) cyclohexyl-N (alpha)-Methyl
toluene-alpha -2-diamine Hydrochloride, represent the Class of Mucolytic Agent or
Expectorant Category. Bromhexine acts on the mucus at the formative stages in the glands,
within the mucus-secreting cells. Bromhexine disrupts the structure of acid muco
polysaccharide fibers in mucoid sputum and produces less viscous mucus, which is easier to
expectorate.[1] Guaiphenesin is a (RS) -3-(2-Methoxy phenoxy) propane-1, 2-diol. , represent
the Class of Bronchial Secretion Enhancer. Guaiphenesin is thought to act as an expectorant
by increasing the volume and reducing the viscosity of secretions in the trachea and bronchi.
It has been said to aid in the flow of respirator.[2] Chlorpheniramine Maleate is a [3-(4-
Chlorophenyl)-3- (pyridine-2-yl)propyl] dim ethylamine, represent the Class of Histamine H1
Antagonist . Chlorpheniramine binds to the histamine H1 receptor. This block the action of
endogenous histamine, which subsequently leads to temporary relief of the negative
symptoms brought on by histamine.[3] Literature Review related that few analytical Methods
[4-9]
have been reported for BH with other combination like UV Spectrophotometry ,
[10-19] [20-21]
HPLC , and HPTLC. Literature review related that few analytical Methods have
[22-30]
been reported for GP with other combination like HPLC , UV Spectrophotometry.[31-34]
Literature Review related that few analytical methods have been reported for CPM with other
[35-42]
combination like UV Spectrophotometry , HPLC.[43-53] The Present work describes a
validated reverse phase HPLC Method for Simultaneous determination of these drugs in
tablet.
EXPERIMENTAL WORK
Instrument and Apparatus
RP-HPLC instrument (Younglin, Korea) equipped with a PDA detector (YL-9160)
Rheodyne injector (20 l Capacity), C18, 250mm 4 .6mm, 5m (Particle size), Bischoff
Chromatography with YL-Clarity Model 1900 as software.
Chromatographic Condition
Stationary phase: Water Spheris orb CNRP C18 Column (250 4.6 mm, 5m).
Mobile phase: Acetonitrile : 0.01 M Potassium dihydrogen phosphate pH-3 Adjusted
with 1% of O- phosphoric acid.(60:40 %v/v)
Detector: 254 nm
Injection volume: 20 l
Flow rate: 1.5 ml/min
Temperature: RT
Run time: 12 minutes
Preparation of Solutions
Preparation of Buffer (pH 3)(0.01 M KH2PO4)
An accurately weighed 0.6804 gm of potassium dihydrogen phosphate (0.01M) was
transferred into 500ml Volumetric Flask, Followed by addition of 300 ml of HPLC Grade
Water. Resulting solution was shaken for 5 min. Sonicated for 15 minute. Then resulting
solution filtered and transferred to another 500 ml Volumetric Flask& Volume was make up
to mark with HPLC grade Water. Then pH 3 was adjusted with ortho phosphoric acid (1%),
above solution filtered with vacuum filter using filter membrane (filter disc) (0.45m)
40 ml of Buffer and 60 ml Acetonitrile was mixed and solution was sonicated for degassing.
methanol. Solution was sonicated for 15 minutes. Filtered the Solution with 0.45 Membrane
filter. Volume was made up to mark with methanol to give a 200g/ml of Bromhexine
hydrochloride, 2500 g/ml of Guaiphenesin and 100 g/ml of Chlorpheniramine Maleate.
From this solution 1ml solution was pipette out and transferred in 10 ml volumetric flask and
volume was made up to mark with methanol to obtain 20 g/ml of Bromhexine
hydrochloride,250 g/ml of Guaiphenesin and 10 g/ml of Chlorpheniramine Maleate.
Above solution was filtered through the membrane filter and injected using syringe.
In the present study, standard solution of BH, GP and CPM were scanned over the range of
200-400nm wavelengths. The both drugs showed good absorbance at 254 nm. So the 254 nm
was selected for simultaneous estimation of BH, GP and CPM in solid dosage forms.
A) VALIDATION
RESULT AND DISCUSSION
Linearity
Standard stock solution of Bromhexine hydrochloride (1000g/ml), Guaiphenesin
(1000g/ml) and Chlorpheniramine Maleate (1000 g/ml) were diluted 10 ml of Volumetric
flask. To get the final concentration of Bromhexine Hydrochloride was 10, 20, 30, 40, 50, 60
g/ml, Guaiphenesin was 125, 250, 375, 500, 625, 750 g/ml and Chlorpheniramine Maleate
was 5, 10, 15, 20, 25, 30 g/ml. All resulting solution were Scanned in HPLC and Plot the
graph of Area Vs Concentration.
Calibration Curve were Plotted over a Concentration Range of 10-60g/ml, 125-750 g/ml
and 5-30 g/ml of BH, GP and CPM Respectively.
Precision
Repeatability
Repeatability expresses the precision under the same operating conditions over a short
Interval of time. Six repeated injections of standard solutions were made and the response
factor of drug peaks and percentage RSD were calculated. Repeatability data for BH, GP, and
CPM are summarized in (Table 2)
Interday Precision was performed by analyzing three different concentrations (g/ml) within
linearity range, on three consecutive days. Interday Precision data of BH, GP and CPM are
summarized in Table 3, Table 4 and Table 5 respectively. %RSD for Interday Precision were
found to be 0.32-0.50 for BH, 0.92-1.37 for GP and 0.35-0.63 for CPM.
Accuracy (% Recovery)
Accuracy study was performed by addition of known amounts of standard drugs to a pre
analyzed sample of commercial product (standard addition method). Recovery by standard
addition method is shown in Table 6. The effect of the excipient and other additive present in
the validity of the suggested procedures was assessed by applying the standard addition
technique, which showed no interference during determination. Standard drug was added at
three different concentrations (10, 20, 30 g/ml of BH, 125,250,375 of GP and 5, 10, 15
g/ml for CPM to sample) and mixture were analyzed by proposed method. The good
recoveries prove the good accuracy of the proposed Methods.
Limit of Detection
Limit of detection for BH, GP and CPM was found to be 1.449g/ml,15.02g/ml and 0.795
g/ml respectively.
Limit of Quantification
Limit of Quantification for BH, GP and CPM was found to be 4.830g/ml, 50.08g/ml and
2.651g/ml respectively
Robustness
The method was found to be robust. Robustness was carried by varying parameters from the
optimized chromatographic conditions.
CONCLUSION
The developed method was validated for various parameters like accuracy, recovery, linearity
as per ICH guidelines. The result obtain were within the acceptance criteria for the respective
parameters. The proposed method was applied for the estimation of Bromhexine
Hydrochloride, Guaiphenesin and Chlorpheniramine Maleate in marketed formulations. The
assay results conformed to the label claim of the formulation.
ACKNOWLEDGEMENTS
The Authors are thankful to Mediwin Pharmaceutical Lab. and Kamron Analytical Lab. At
Ahmedabad, for Providing Samples of Pure Drug API. The authors are also thankful to
Saraswati Institute of Pharmaceutical Sciences for providing necessary Equipment, Facility
and Chemicals.
REFERENCES
1. BromhexineHydrochloride,Sep2014,http://www.drugbank.ca/drugs DB09019
2. Guaiphenesin ,Sep2014http://www.drugbank.ca/drugs/DB00874
3. ChlorpheniramineMaleate,Sep2014http://www.drugbank.ca/drugs/DB01114
4. N S Othman and S A Omer, Indirect Spectrophotometric method for Determination of
sBromhexine hydrochloride in pharmaceutical Preparation. Raf.J. Sci. 2008; 19(2): 16-
27.
5. K Susmitha, M Thirumalachary and G. Venkateshwarly, Spectrophotometric
Determination of Bromhexine Hydrochloride in pure and pharmaceutical forms.
Hindwadi Publishing Corporation. ISRN Anal. chem. 2013; 1-7.
16. A porel, S Haty and A Kundu, Stability indicating HPLC method for Simultaneous
Determination of Terbutaline sulphate, Bromhexine hydrochloride and Guaiphenesin.
Int J. Pharm Sci. 2011; 73(1): 46-56.
17. S Safeena, S Asghar and S Ahmad, RP-HPLC Method for the Simultaneous estimation
of Phenyl ephedrine hydrochloride, Guaiphenesin, Cetrizine Hydrochloride, Bromhexine
hydrochloride in pharmaceutical formulation. Int J. PharmRes Scholars. 2013; 2(4):
448-457.
18. P SMehta and V B Patel, RP-HPLC Method for Simultaneous estimation of
Bromhexine hydrochloride, Dextromethorphan hydro bromide, Guaiphenesin in Soft Gel
Capsule. Asian J.Chem. 2013; 25(6): 3341-3343.
19. K Nalini, P Narmada, G Vijayalakshmi, Y Gowtham and K V Jogi, Simultaneous
estimation of Paracetamol ,Guaiphenesin , Phenylepherine hydrochloride ,
Chlorpheniramine maleate and Bromhexine hydrochloride in combined tablet dosage
form by RP-HPLC. , Int. J . Pharm Sci Res. 2014; 5(2): 410-416.
20. S Safeena, S Asghar and S Ahmad, A Validated and stability indicating HPTLC Method
for the Simultaneous estimation of Terbutaline Sulphate, Bromhexine hydrochloride, and
Guaiphenesin in Pharmaceutical formulation. Int J. Pharma.2013; 3(1): 200-210.
21. M VDhoka, V DGowanda and P P Joshi, HPTLC Determination of Amoxicillin
Trihydrate and Bromhexine hydrochloride in oral solid dosage forms. J .PharmSciRes.
2010; 2(8): 477-483.
22. S P Readdy, K S Babu and Y V V S Sekhar , Development and Validation Of Stability
Indicating the RP-HPLC Method For the Estimation of Related Compounds Of
Guaiphenesin in Pharmaceutical dosage Forms. Pharm Methods.2011; 2(4): 229-234.
23. M Abdelkawy, F Metwaly , N El Raghy , M Hegazy and N Fayek, Simultaneous
determination of Ambroxol Hydrochloride and Guaiphenesin by HPLC , TLC
Spectrodensitometric and Multivariate Calibration Methods in Pure Form and in Cough
Cold Formulation . J. Chromatograph Separat Techniq. 2011; 2(3): 1-9.
24. S Rahul, NPS Sengar, M DParulandNS Lodhi, A Validated RP-HPLC Method for
Determination of Guaiphenesin and Pseudoephedrine Hydrochloride in Tablet Dosage
Form. Int J. Pharm. 2012; 2(2): 317-321.
25. T V RaghavaRaju, N Anil Kumar and S Raja kumar, Development and
Validation Of a Stability Indicating RP-HPLC Method for Simultaneous Estimation of
Guaiphenesin and Dextromethorphan Impurity in Pharmaceutical
Formulation.Hindwadi Publishing Corporation. Chromatograph Res Int.2013; 1-12.